- $384.53m
- $4.89bn
- $930.62m
- 44
- 44
- 77
- 55
Annual income statement for Claritev, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 938 | 1,118 | 1,080 | 962 | 931 |
Cost of Revenue | |||||
Gross Profit | 619 | 942 | 876 | 726 | 691 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,173 | 747 | 1,408 | 746 | 2,379 |
Operating Profit | -235 | 370 | -328 | 216 | -1,448 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -547 | 135 | -561 | -107 | -1,771 |
Provision for Income Taxes | |||||
Net Income After Taxes | -521 | 102 | -573 | -91.7 | -1,646 |
Net Income Before Extraordinary Items | |||||
Net Income | -521 | 102 | -573 | -91.7 | -1,646 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -521 | 102 | -573 | -91.7 | -1,646 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -36.8 | 7.88 | -8.75 | -7.4 | -39.5 |